Gateway to Think Tanks
来源类型 | Commentary |
规范类型 | 评论 |
Drug Prices: U.S. Patients Not First | |
Vivian Ho; Hagop M. Kantarjian | |
发表日期 | 2018-07-02 |
出版年 | 2018 |
语种 | 英语 |
概述 | The Trump administration's "American Patients First" plan is a green light for drug companies to continue their unfettered pricing schemes ... |
摘要 | The Trump administration's "American Patients First" plan is a green light for drug companies to continue their unfettered pricing schemes write the authors, who offer three steps to lower prescription drug prices in the U.S. The Hill: https://bit.ly/2KJuQt7 |
主题 | Center for Health and Biosciences |
URL | https://www.bakerinstitute.org/research/american-patients-are-not-first/ |
来源智库 | James A. Baker III Institute for Public Policy (United States) |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/80320 |
推荐引用方式 GB/T 7714 | Vivian Ho,Hagop M. Kantarjian . Drug Prices: U.S. Patients Not First. 2018. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。